Paul McBarron, EVP, Finance, CFO, COO at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 12,000 shares at $0.50 ($6K) on 2011-09-23, disclosed to the SEC on 2011-09-26.
Open-market purchase of $6k CYCC by EVP, Finance, CFO, COO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CYCC | BUY | 2008-05-23 | $4K | — | Filing → |